Advertisement
Advertisement
U.S. markets open in 2 hours 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.02+0.18 (+1.83%)
At close: 04:00PM EDT
10.02 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
52,386
55,311
71,857
73,414
60,370
Cost of Revenue
-
-
0
0
715
Gross Profit
-
-
71,857
73,414
59,655
Operating Expense
204,670
301,315
369,614
325,329
298,406
Operating Income
-152,284
-246,004
-297,757
-251,915
-238,751
Net Non Operating Interest Income Expense
-44,706
-45,780
-40,144
-23,467
1,484
Other Income Expense
95,872
92,207
51,364
33,705
11,182
Pretax Income
-101,118
-199,577
-286,537
-241,677
-226,085
Tax Provision
361
-151
-8,520
-5,222
-10,561
Net Income Common Stockholders
-101,479
-199,426
-278,017
-236,455
-215,524
Diluted NI Available to Com Stockholders
-101,479
-199,426
-278,017
-236,455
-215,524
Basic EPS
-
-2.87
-4.46
-4.25
-3.99
Diluted EPS
-
-2.87
-4.46
-4.25
-3.99
Basic Average Shares
-
69,461
62,345
55,610
53,969
Diluted Average Shares
-
69,461
62,345
55,610
53,969
Total Operating Income as Reported
-175,163
-257,784
-297,757
-251,915
-238,751
Total Expenses
204,670
301,315
369,614
325,329
299,121
Net Income from Continuing & Discontinued Operation
-101,479
-199,426
-278,017
-236,455
-215,524
Normalized Income
-87,752
-187,655
-263,012
-236,455
-215,524
Interest Income
2,237
1,109
4,441
8,395
11,966
Interest Expense
46,943
46,889
44,585
31,862
10,482
Net Interest Income
-44,706
-45,780
-40,144
-23,467
1,484
EBIT
-54,175
-152,688
-241,952
-209,815
-215,603
EBITDA
-45,491
-
-
-
-
Reconciled Cost of Revenue
-
-
0
0
715
Reconciled Depreciation
8,684
9,708
9,063
6,214
3,166
Net Income from Continuing Operation Net Minority Interest
-101,479
-199,426
-278,017
-236,455
-215,524
Total Unusual Items Excluding Goodwill
-22,879
-11,780
-15,464
0
0
Total Unusual Items
-22,879
-11,780
-15,464
0
0
Normalized EBITDA
-22,612
-131,200
-217,425
-203,601
-212,437
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9,152
-9.424
-459.2808
0
0
Advertisement
Advertisement